qPCR Reagents Market is segmented By Detection Method ( Dye-Based qPCR Reagents *, Probes and Primer-Based qPCR Reagents), By Packaging Type ( qPCR Core Kits*, qPCR Mastermixes), By Application ( Diagnostic*, Research, Forensic), By End-User ( Hospitals and Diagnostic Centers*, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029
qPCR Reagents Market is estimated to reach a high CAGR of 8.3% during the forecast period 2022-2029.
qPCR Reagents Market - Strategic Insights
Metrics |
Details |
Market CAGR |
8.3% |
Segments Covered |
By Detection Method, By Packaging Type, By Application, End-User, and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Fastest Growing Region |
Asia Pacific |
Largest Market Share |
North America |
To Get a Free Sample Click here
A real-time polymerase chain reaction (real-time PCR) or quantitative polymerase chain reaction (qPCR) is a laboratory technique of molecular biology based on the polymerase chain reaction (PCR). It monitors the amplification of a targeted DNA molecule during the PCR.
Market Dynamics:
The qPCR Reagents market growth is driven by the rising incidence of infectious and genetic diseases has increased the demand for diagnostic tests that may help people take preventive measures, technological advancements in the life sciences sector, increasing public-private investments, funds, grants for PCR-based research, and the successful completion of the human genome project.
The rising incidence of target infectious diseases and genetic disorders is expected to drive the market growth
The demand for genomic analysis techniques has grown steadily during the last decade due to their increasing use in diagnosing major infectious diseases (such as HIV, tuberculosis, malaria, and hepatitis) and genetic disorders (such as cancer). The rise in the prevalence of target diseases globally, coupled with the proven efficacy of qPCR and dPCR analysis in the diagnosis and estimation of disease-causing microbes, will boost the use of clinical diagnostic tests (including qPCR and dPCR analysis) and support market growth. For instance, according to UNAIDS, as of 2019, approximately 38.0 million people were suffering from HIV-AIDS globally, with an average mortality of 0.69 million. Of these, 1.7 million new HIV infection cases were reported in 2019 alone. In 2019, around 10.0 million new TB cases were registered worldwide (WHO data, 2019). Moreover, approximately 228 million patients were suffering from malaria globally in 2019, with 94% of cases registered in the African region alone.
High costs associated with qPCR is likely to hamper the market growth
A typical PCR analysis conducted through qPCR instruments involves several scientific technologies (PCR, microfluidics, and nanofabrication) integrated to achieve the desired outcome. These instruments are small and boast reduced cycle times. However, the development of such instruments requires large capital investments and extensive scientific validation on a nanoscale level. qPCR instruments cost ~USD 50,000. Such high prices have resulted in the subdued adoption of qPCR instruments among price-sensitive end-users.
COVID-19 Impact Analysis:
The COVID-19 pandemic impacted several aspects of the healthcare industry, but the diagnostics industry was the most impacted. The PCR industry has been impacted positively. Digital PCR and real-time PCR utilized in diagnostic and drug discovery have witnessed major demand. Industry players are focusing on developing droplet digital PCR kit tests to detect COVID-19. Regulatory authorities also have extended support to approve these tests to combat the consequences of the COVID-19 pandemic.
Several companies have changed their business model to sustain the pandemic situation. For instance, Roche witnessed a negative growth of 5.3% in its Life Science segment in 2020 compared to 2019, due to which the company increased its focus on R&D to develop COVID-19 droplet digital PCR kits, which helped it boost its revenue growth.
Segment Analysis:
The dye-based qPCR Reagents segment is expected to hold the largest share in this market segment
Using fluorescent DNA-binding dyes is one of the most straightforward and common qPCR approaches of scientists. A dye is added to the reaction, and fluorescence is measured at each PCR cycle. Because fluorescence of these dyes increases dramatically in the presence of double-stranded DNA, DNA synthesis can be monitored as an increase in fluorescent signal.
Dye-based diagnostic qualitative PCR is applied to rapidly detect nucleic acids that are diagnostic of, for example, infectious diseases, cancer and genetic abnormalities. Moreover, Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in the incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040. This is an increase of 61.7% from 2018 (17 million).
qPCR Reagents Market Scope
Geographical Analysis:
North America region holds the largest market share of global qPCR Reagent’s market
The prevalence of cancer in the United States is one of the highest in North American countries. According to a 2018 report by the National Cancer Institute, cancer incidence in the US is 439.2 per 100,000 men and women per year. The prevalence of infectious diseases is also high in the United States and Mexico. This has created high demand for qPCR diagnostic tests, increasing the demand for qPCR Reagents.
However, the United States has a developed and well-structured health care system. The system also encourages research and development. These policies encourage global players to enter the US, and eventually, the North American market. As a result, this region enjoys the presence of many global market players. As global players in the region meet high demand, the market is further expected to increase.
Competitive Landscape:
The global qPCR Reagents market is highly competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Affymetrix Inc, Promega Corporation, Quanta Biosciences Inc, Takara Bio, Bio-Rad Laboratories Inc, Sigma-Aldrich Corporation (Merck KGaA), Thermo Fisher Scientific, Agilent Technologies, Inc, F. Hoffman-La Roche Ltd and Qiagen N.V. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, Thermo Fisher developed several PCR kits and assays for diagnostics and research applications. The company received the US FDA emergency use authorization (EUA) for SARS‑CoV‑2 multiplex real-time PCR test and also launched AcroMetrix Coronavirus 2019 (COVID-19) RNA Control in 2020.
qPCR Reagents Market – Market Key Companies to Watch
Bio-Rad Laboratories, Inc
Overview: Bio-Rad Laboratories, Inc. is an American company founded in 1992, headquartered in California, United States. The company has over 8,000 employees and operates through three business segments: life science, clinical diagnostics, and other operations. Moreover, Bio-Rad’s diagnostic products and systems use various technologies and provide clinical information in the blood transfusion, diabetes monitoring, autoimmune, and infectious disease testing markets. These products support the diagnosis, monitoring, and treatment of diseases and other medical conditions.
Product Portfolio: It provides fluorescence detection chemistries for qPCR that can be categorized into two major types: DNA-binding dyes such as SYBR Green I, and dye-labelled, sequence-specific oligonucleotide probes such as TaqMan probes.
Key Developments: On 30th June 2021, Bio-Rad announced a partnership with Seegene for molecular diagnostic testing products. Under the terms of the agreement, Seegene will provide diagnostic tests for use on Bio-Rad's CFX96 Dx Real-Time PCR System for U.S. markets.
Frequently Asked Questions
What is the Projected CAGR value of the qPCR Reagents Market ?
qPCR Reagents Market is expected to grow at a CAGR of 8.3% during the forecasting period 2022-2029.
Which region controlled the global market during 2022-2029?
North America region Controls the qPCR Reagents Market during 2022-2029
Which is the fastest growing region in the qPCR Reagents Market?
Among all regions, Asia Pacific is the fastest growing market share during the forecast period